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Adaptive designs that are based on group-sequential
approaches have the benefit of being efficient as stop-
ping boundaries can be found that lead to good operat-
ing characteristics with test decisions based solely on
sufficient statistics. The drawback of these so called
“pre-planned adaptive” designs is that unexpected design
changes are not possible without impacting the error
rates. “Flexible adaptive designs”, and in particular
designs based on p-value combination, on the other
hand can cope with a large number of contingencies at
the cost of reduced efficiency.
In this presentation we focus on so called multi-arm
multi-stage trials which compare several active treatments
against control at a series of interim analysis. We will dis-
cuss how these “pre-planned adaptive designs” can be
modified to allow for flexibility. We then show how the
added flexibility can be used for treatment selection and
evaluate the impact on power in a simulation study. The
results show that a combination of a well chosen pre-
planned design and an application of the conditional
error principle to allow flexible treatment selection results
in an impressive overall procedure.
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